| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 37 | 2023 | 832 | 6.020 |
Why?
|
| Neoplasms | 38 | 2024 | 3325 | 4.070 |
Why?
|
| Mutation | 42 | 2024 | 4389 | 3.410 |
Why?
|
| Genomics | 19 | 2023 | 896 | 2.920 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2024 | 1391 | 1.930 |
Why?
|
| Oncogenes | 8 | 2024 | 102 | 1.810 |
Why?
|
| Gene Fusion | 5 | 2023 | 41 | 1.520 |
Why?
|
| DNA Copy Number Variations | 14 | 2020 | 201 | 1.420 |
Why?
|
| Computational Biology | 7 | 2020 | 611 | 1.360 |
Why?
|
| Sequence Analysis, DNA | 12 | 2022 | 911 | 1.290 |
Why?
|
| Gene Rearrangement | 6 | 2020 | 174 | 1.250 |
Why?
|
| Whole Genome Sequencing | 12 | 2024 | 117 | 1.210 |
Why?
|
| Chromothripsis | 4 | 2022 | 9 | 1.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 567 | 1.200 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2024 | 43 | 1.080 |
Why?
|
| Evolution, Molecular | 9 | 2020 | 902 | 0.880 |
Why?
|
| Genomic Structural Variation | 4 | 2020 | 9 | 0.850 |
Why?
|
| DNA Replication | 1 | 2024 | 169 | 0.810 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2024 | 298 | 0.810 |
Why?
|
| Adenocarcinoma | 6 | 2020 | 1208 | 0.790 |
Why?
|
| Algorithms | 5 | 2024 | 2008 | 0.790 |
Why?
|
| Exome | 7 | 2020 | 145 | 0.770 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 548 | 0.700 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 1100 | 0.690 |
Why?
|
| Humans | 66 | 2024 | 97913 | 0.670 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 840 | 0.660 |
Why?
|
| DNA Transposable Elements | 6 | 2011 | 170 | 0.640 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1133 | 0.610 |
Why?
|
| RNA, Long Noncoding | 4 | 2024 | 132 | 0.600 |
Why?
|
| Genome, Plant | 6 | 2011 | 107 | 0.580 |
Why?
|
| Retroelements | 5 | 2020 | 50 | 0.540 |
Why?
|
| Transcriptome | 7 | 2023 | 818 | 0.530 |
Why?
|
| Virus Integration | 4 | 2020 | 17 | 0.510 |
Why?
|
| Exons | 2 | 2020 | 450 | 0.500 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2017 | 285 | 0.490 |
Why?
|
| Chromatin | 4 | 2022 | 454 | 0.490 |
Why?
|
| Telomere | 3 | 2020 | 130 | 0.450 |
Why?
|
| Zea mays | 3 | 2009 | 30 | 0.450 |
Why?
|
| Signal Transduction | 13 | 2020 | 3615 | 0.450 |
Why?
|
| Databases, Genetic | 7 | 2020 | 288 | 0.450 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2020 | 14 | 0.440 |
Why?
|
| Genomic Instability | 3 | 2024 | 90 | 0.440 |
Why?
|
| Telomerase | 6 | 2020 | 69 | 0.430 |
Why?
|
| Disease Progression | 1 | 2019 | 1607 | 0.430 |
Why?
|
| Melanoma | 2 | 2017 | 519 | 0.420 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2020 | 103 | 0.420 |
Why?
|
| RNA Splicing | 2 | 2020 | 162 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2020 | 461 | 0.400 |
Why?
|
| Models, Genetic | 1 | 2019 | 1004 | 0.400 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 2453 | 0.390 |
Why?
|
| Gene Expression Profiling | 8 | 2023 | 1566 | 0.390 |
Why?
|
| Stomach Neoplasms | 2 | 2017 | 317 | 0.380 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 1101 | 0.370 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 1831 | 0.370 |
Why?
|
| Molecular Targeted Therapy | 5 | 2017 | 320 | 0.360 |
Why?
|
| Gene Dosage | 4 | 2020 | 216 | 0.350 |
Why?
|
| Carcinoma | 1 | 2014 | 440 | 0.340 |
Why?
|
| Software | 2 | 2020 | 694 | 0.340 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 138 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 1086 | 0.330 |
Why?
|
| DNA Tumor Viruses | 1 | 2020 | 1 | 0.310 |
Why?
|
| Cloud Computing | 2 | 2020 | 14 | 0.310 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 635 | 0.310 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 468 | 0.300 |
Why?
|
| Tumor Virus Infections | 1 | 2020 | 83 | 0.300 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 400 | 0.300 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2024 | 304 | 0.300 |
Why?
|
| DNA Methylation | 8 | 2020 | 730 | 0.300 |
Why?
|
| Tumor Hypoxia | 1 | 2020 | 53 | 0.300 |
Why?
|
| Carcinogenesis | 2 | 2020 | 241 | 0.290 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 556 | 0.290 |
Why?
|
| Oncogene Fusion | 2 | 2020 | 10 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 5 | 2020 | 976 | 0.290 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 164 | 0.290 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 226 | 0.290 |
Why?
|
| Plants | 1 | 2009 | 122 | 0.280 |
Why?
|
| Male | 16 | 2024 | 46983 | 0.280 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 582 | 0.270 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 419 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2018 | 384 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2020 | 1445 | 0.260 |
Why?
|
| Glioblastoma | 4 | 2015 | 298 | 0.260 |
Why?
|
| Genome | 3 | 2022 | 417 | 0.250 |
Why?
|
| Mutation Rate | 3 | 2020 | 57 | 0.250 |
Why?
|
| DNA, Neoplasm | 3 | 2020 | 267 | 0.240 |
Why?
|
| Kidney Neoplasms | 3 | 2018 | 556 | 0.240 |
Why?
|
| DNA, Intergenic | 2 | 2020 | 28 | 0.240 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2017 | 137 | 0.230 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 220 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 369 | 0.230 |
Why?
|
| Nuclear Proteins | 4 | 2022 | 749 | 0.220 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2024 | 15 | 0.220 |
Why?
|
| Tandem Repeat Sequences | 1 | 2024 | 31 | 0.220 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2024 | 65 | 0.210 |
Why?
|
| Animals | 9 | 2024 | 28864 | 0.210 |
Why?
|
| Mutagenesis, Insertional | 4 | 2020 | 103 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2024 | 88 | 0.210 |
Why?
|
| Female | 15 | 2024 | 51441 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 353 | 0.200 |
Why?
|
| Genes, p53 | 2 | 2015 | 108 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 322 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1787 | 0.200 |
Why?
|
| Base Sequence | 8 | 2020 | 2222 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 2884 | 0.190 |
Why?
|
| Genes, Neoplasm | 3 | 2018 | 39 | 0.190 |
Why?
|
| Glioma | 2 | 2016 | 309 | 0.190 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 2896 | 0.190 |
Why?
|
| Starfish | 1 | 2022 | 5 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2020 | 1757 | 0.180 |
Why?
|
| DNA Repair | 4 | 2020 | 363 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 2555 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 2 | 2020 | 124 | 0.170 |
Why?
|
| Mutagenesis | 2 | 2020 | 195 | 0.170 |
Why?
|
| Tachykinins | 1 | 2021 | 14 | 0.170 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2021 | 18 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2785 | 0.160 |
Why?
|
| Genes, Plant | 5 | 2012 | 97 | 0.160 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 150 | 0.160 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 34 | 0.150 |
Why?
|
| Mice | 4 | 2024 | 12682 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2020 | 110 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2022 | 447 | 0.140 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 1088 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2020 | 132 | 0.140 |
Why?
|
| Transcription Factors | 5 | 2018 | 1711 | 0.140 |
Why?
|
| Proteome | 3 | 2014 | 163 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2060 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2020 | 350 | 0.130 |
Why?
|
| Mice, Nude | 2 | 2017 | 830 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2017 | 12 | 0.130 |
Why?
|
| Proteogenomics | 1 | 2017 | 8 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2020 | 518 | 0.120 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 4 | 0.120 |
Why?
|
| DNA | 1 | 2022 | 1274 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 402 | 0.120 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2016 | 18 | 0.120 |
Why?
|
| MicroRNAs | 4 | 2016 | 603 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 113 | 0.120 |
Why?
|
| Chromosomes, Plant | 3 | 2009 | 40 | 0.110 |
Why?
|
| RNA | 1 | 2020 | 593 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2020 | 130 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 156 | 0.110 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 75 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 225 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 125 | 0.110 |
Why?
|
| Chromosome Aberrations | 2 | 2013 | 352 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 87 | 0.110 |
Why?
|
| ras Proteins | 1 | 2015 | 137 | 0.110 |
Why?
|
| X-linked Nuclear Protein | 2 | 2020 | 11 | 0.110 |
Why?
|
| Molecular Typing | 1 | 2014 | 19 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 588 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 271 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2020 | 715 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2014 | 183 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 165 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2015 | 332 | 0.100 |
Why?
|
| DNA, Plant | 2 | 2009 | 46 | 0.100 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 824 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 10 | 0.090 |
Why?
|
| Thyroid Gland | 1 | 2014 | 296 | 0.090 |
Why?
|
| Eragrostis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2014 | 212 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 682 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 529 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 249 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2019 | 3207 | 0.090 |
Why?
|
| Bryopsida | 2 | 2011 | 2 | 0.090 |
Why?
|
| Child | 1 | 2023 | 7687 | 0.090 |
Why?
|
| Selaginellaceae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2012 | 353 | 0.080 |
Why?
|
| Biological Evolution | 2 | 2011 | 1067 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2020 | 1152 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 336 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2854 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1138 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 581 | 0.080 |
Why?
|
| Base Composition | 1 | 2020 | 36 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 489 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 1255 | 0.080 |
Why?
|
| MEF2 Transcription Factors | 1 | 2020 | 9 | 0.080 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2020 | 10 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 240 | 0.080 |
Why?
|
| Genes, myc | 1 | 2020 | 38 | 0.080 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 26 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2016 | 402 | 0.080 |
Why?
|
| Hepatitis B virus | 1 | 2020 | 49 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 1849 | 0.080 |
Why?
|
| Base Pairing | 1 | 2009 | 55 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 139 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 79 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 45 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 125 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 191 | 0.070 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 113 | 0.070 |
Why?
|
| Cenchrus | 1 | 2008 | 1 | 0.070 |
Why?
|
| Pennisetum | 1 | 2008 | 1 | 0.070 |
Why?
|
| Reproduction, Asexual | 1 | 2008 | 3 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 172 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 424 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 367 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 73 | 0.060 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2017 | 2 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2017 | 32 | 0.060 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2017 | 12 | 0.060 |
Why?
|
| Keratins | 1 | 2017 | 62 | 0.060 |
Why?
|
| HLA-A Antigens | 1 | 2017 | 39 | 0.060 |
Why?
|
| Receptor, ErbB-3 | 1 | 2017 | 19 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 51 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 461 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 45 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 4105 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 211 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2017 | 100 | 0.060 |
Why?
|
| RNA, Plant | 3 | 2011 | 19 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 308 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1616 | 0.060 |
Why?
|
| Open Reading Frames | 2 | 2020 | 118 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 311 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 184 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 611 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1995 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 1086 | 0.060 |
Why?
|
| Age Factors | 1 | 2020 | 1967 | 0.060 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 2 | 0.050 |
Why?
|
| Proteomics | 1 | 2017 | 278 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2017 | 330 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 1527 | 0.050 |
Why?
|
| Oryza | 3 | 2009 | 49 | 0.050 |
Why?
|
| Gene Duplication | 3 | 2009 | 129 | 0.050 |
Why?
|
| Apoptosis | 1 | 2020 | 1750 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 334 | 0.050 |
Why?
|
| United States | 1 | 2015 | 8155 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2020 | 22 | 0.040 |
Why?
|
| DNA Breaks | 1 | 2020 | 4 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 35 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 61 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 3267 | 0.040 |
Why?
|
| Magnoliopsida | 2 | 2011 | 28 | 0.040 |
Why?
|
| Sorghum | 2 | 2009 | 5 | 0.040 |
Why?
|
| Synteny | 2 | 2009 | 31 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 177 | 0.040 |
Why?
|
| beta Catenin | 1 | 2020 | 267 | 0.040 |
Why?
|
| Plant Proteins | 2 | 2011 | 131 | 0.040 |
Why?
|
| Phenotype | 2 | 2018 | 2638 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2017 | 7 | 0.030 |
Why?
|
| Monosomy | 1 | 2017 | 12 | 0.030 |
Why?
|
| Receptor, trkC | 1 | 2017 | 6 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2017 | 32 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 108 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 512 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 322 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2022 | 499 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 111 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1274 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 273 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 565 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 263 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 212 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 169 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 66 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 10922 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1947 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 63 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 91 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 61 | 0.030 |
Why?
|
| Poly A | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 107 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 15 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 220 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 150 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 69 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 214 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 422 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 767 | 0.020 |
Why?
|
| Phylogeny | 2 | 2011 | 1337 | 0.020 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 12 | 0.020 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2013 | 17 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 830 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 902 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 895 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 920 | 0.020 |
Why?
|
| Mutagens | 1 | 2012 | 29 | 0.020 |
Why?
|
| Ethiopia | 1 | 2012 | 37 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 81 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2012 | 68 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 10078 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2033 | 0.020 |
Why?
|
| Chlamydomonas | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 814 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2011 | 98 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 310 | 0.020 |
Why?
|
| RNA Editing | 1 | 2011 | 47 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 28 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 26 | 0.020 |
Why?
|
| Crops, Agricultural | 1 | 2009 | 17 | 0.020 |
Why?
|
| Ploidies | 1 | 2009 | 39 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 157 | 0.020 |
Why?
|
| Inbreeding | 1 | 2009 | 49 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 32 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2009 | 263 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2007 | 19 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 423 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 581 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 204 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2008 | 144 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 1061 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 29366 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 29498 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 346 | 0.010 |
Why?
|
| Arabidopsis | 1 | 2007 | 331 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 2440 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 21703 | 0.010 |
Why?
|